Laboratory Information:
National Cancer Institute
Bethesda, MD 20892
Website: http://www.cancer.gov
Technology Transfer Website: http://ttc.nci.nih.gov/
Agency/Department: Dept. of Health and Human Services
Region: Mid-Atlantic
FLC Laboratory Representative:
Ms. Karen Maurey
Phone: (240) 276-5530
Fax: (240) 276-5504
Email: maureyk@mail.nih.gov
Background/History of the Laboratory:
The National
Cancer Institute (NCI) is a component of the National
Institutes of Health (NIH), one of eight agencies that
compose the Public Health Service (PHS) in the Department of
Health and Human Services (DHHS). The NCI, established under
the National Cancer Act of 1937, is the Federal
Government's principal agency for cancer research and
training. The National Cancer Act of 1971 broadened the scope
and responsibilities of the NCI and created the National
Cancer Program. Over the years, legislative amendments have
maintained the NCI authorities and responsibilities and added
new information dissemination mandates as well as a
requirement to assess the incorporation of state-of-the-art
cancer treatments into clinical practice.
The National Cancer Institute coordinates the National Cancer
Program, which conducts and supports research, training,
health information dissemination, and other programs with
respect to the cause, diagnosis, prevention, and treatment of
cancer, rehabilitation from cancer, and the continuing care
of cancer patients and the families of cancer
patients.
Accomplishments
in Technology Transfer:
AIDS test kits,
Fludara®, Gardasil®, HIVID®, Kepivance®,
Multi-replica blotting kit for proteins, NeuTrexin®,
PathVysion® HER-2 DNA probe kit, PhenoSenseTM HIV
phenotype tests, PixCell® Laser Capture Microdissection
system (LCM), Prezista®, soluble IL-2 receptor assays,
Squirrel-Free capsaicin-treated birdseed, Taxol®,
Velcade®, Videx®, Vitravene® and Zevalin®.
More information on NCI success stories can be found at
http://ttc.nci.nih.gov/about/success.php
Mission of the Laboratory:
The National
Cancer Institute supports and coordinate research projects
conducted by universities, hospitals, research foundations,
and businesses throughout this country and abroad through
research grants and cooperative agreements; conducts research
in its own laboratories and clinics; supports education and
training in fundamental sciences and clinical disciplines for
participation in basic and clinical research programs and
treatment programs relating to cancer through career awards,
training grants, and fellowships; supports research projects
in cancer control; supports a national network of cancer
centers; collaborates with voluntary organizations and other
national and foreign institutions engaged in cancer research
and training activities; encourages and coordinates cancer
research by industrial concerns where such concerns evidence
a particular capability for programmatic research; collects
and disseminates information on cancer; supports construction
of laboratories, clinics, and related facilities necessary
for cancer research through the award of construction
grants.
Facilities:
Technology Transfer Mechanisms:
- Clinical Trial Agreements (CTAs)
- Confidential Disclosure Agreements (CDAs)
- Employee Invention Report (EIR)
- Fellowships
- Material Transfers
- Materials-Cooperative Research and Development Agreement (Materials CRADA)
- Natural Products Branch-Developmental Therapeutics Program Memorandum of Understanding (MOU)
- Cooperative Research and Development Agreements (CRADAs)
- Small Business Innovative Research (SBIR)
Technology Areas of Expertise:
- AIDS Cancers
- Analytic Epidemiology
- Applied Cancer Screening
- Basic and Biobehavioral Research
- Basic Prevention Science
- Behavioral Research
- Biochemistry and Pharmacology
- Biological Modifiers
- Biometry
- Cancer and Nutrition
- Cancer Biology
- Cancer Biomarkers
- Cancer Cell Biology
- Cancer Complementary and Alternative Medicine
- Cancer Control and Population Sciences
- Cancer Etiology
- Cancer Genomics
- Cancer Immunology and Hematology
- Cancer Nanotechnology
- Cancer Prevention
- Cancer Statistics
- Cancer Surveillance
- Cancer Survivorship
- Cancer Treatment and Diagnosis
- Chemopreventive Agent Development
- Clinical and Genetic Epidemiology
- Clinical Oncology
- Clinical Proteomics Technology
- Clinical Trials
- Community Oncology Prevention Trials
- Diagnostic Imaging
- Diagnostics Research
- DNA and Chromosome Aberrations
- Drug Discovery
- Early Detection
- Epidemiology and Genetics
- Gastrointestinal and Other Cancers
- Health Communication and Informatics
- Health Promotion
- Health Services and Economics
- Imaging Technology Development
- Integrated Tumor Biology
- Integrated Tumor Biology
- Lung and Upper Aerodigestive Cancer
- Molecular Imaging
- Mouse Models of Human Cancers
- Nutritional Science
- Outcomes Research
- Prostate and Urologic Cancer
- Radiotherapy Development
- Resources Development
- Risk Factor Monitoring and Methods
- Statistical Research and Applictions
- Surgical Oncology
- Surveillance Research
- Technology Development/Cancer Diagnosis Program
- Tobacco Control and Research
- Tumor Biology and Metastasis
